RESEARCH
25 HUMAN CLINICAL TRIALS
COMPLETED
15 HUMAN CLINICAL TRIALS IN THE PIPELINE
By controlling mitochondrial ROS, Mitoquinol mesylate has shown therapeutic potential in a range of disease models and human trials.
Mitoquinol Studies by Year
Current Human Clinical Trials
| Study Title | Clinical Trial Number | Status | Institution |
|---|---|---|---|
| Mitoquinone/Mitoquinol Mesylate as Oral and Safe Postexposure Prophylaxis for Covid-19 | NCT05886816 | Recruiting | University of Texas Southwestern Medical Center |
| Effect of MitoQ on Platelet Function and Reactive Oxygen Species Generation in Patients With Sickle Cell Anemia | NCT04109820 | Recruiting | University of Pittsburgh |
| MitoQ and Exercise Effects on Vascular Health | NCT05686967 | Testing | University of Colorado, Denver |
| MitoQ for Fatigue in Multiple Sclerosis (MS) | NCT04267926 | Testing | VA Office of R&D |
| Impacts of Mitochondrial-targeted Antioxidant on Peripheral Artery Disease Patients | NCT03506633 | Recruiting | University of Nebraska |
| MitoQ Supplementation and Cardiovascular Function in Healthy Men and Women | NCT03586414 | Testing | University of Colorado, Denver |
| Mitochondrial Derived Reactive Oxygen Species on Cardiovascular Health in Chronic Obstructive Pulmonary Disease (COPD) | NCT05605548 | Recruiting | Virginia Commonwealth University |
| Examining the Effects of Mitochondrial Oxidative Stress in DCM | NCT05410873 | Recruiting | Imperial College London |
| Mechanisms for Vascular Dysfunction and Exercise Tolerance in CF | NCT02690064 | Recruiting | Augusta University |
| MARVEL: Mitochondrial Anti-oxidant Therapy to Resolve Inflammation in Ulcerative Colitis | NCT04276740 | Recruiting | University of Edinburgh |
| The Influence of Mitochondrial-Derived Reactive Oxygen Species on Racial Disparities in Neurovascular Function | NCT04334135 | Recruiting | Auburn University |
| MitoQ for the Treatment of Metabolic Dysfunction in Asthma | NCT04026711 | Testing | University of Vermont |